Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline

Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline

Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?

Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?

Q4HE Initiative Recognized for Efforts To Reduce Health Disparities

Myriad Genetics (MYGN) Announces Favorable Research Results

Myriad Genetics (MYGN) Announces Favorable Research Results

My Quest Story - Jessica Clow

Quest Diagnostics' (NYSE:DGX) investors will be pleased with their respectable 62% return over the last five years

Quest Diagnostics Inc's Dividend Analysis

Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay

My Quest Story - Pauline Chaves

She Is Not Skipping a Beat, and Patients Are Noticing

Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease

Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

My Quest Story - Eddy Hurst

Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Colleague Is Exhibiting Care for Every Patient in Her Chair